Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07275970 · ClinicalTrials.gov registry record · Phase 1

Safety and Preliminary Efficacy of Organic Whole Psilocybin-Containing Mushrooms to Treat Patients Suffering From PTSD

A Phase 1 study of PTSD, sponsored by Suzanne "Sue" Sisley MD.

Recruiting
Registry status
Phase 1
Development phase
24
Enrollment target
1
Study location

NCT07275970 is a Phase 1 study of PTSD that is actively recruiting participants, run by Suzanne "Sue" Sisley MD. The registered enrollment target is 24 participants, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07275970, a Phase 1 study of PTSD, is actively recruiting participants, sponsored by Suzanne "Sue" Sisley MD.

RECRUITING
Registry status
Phase 1
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

This study will examine the safety and preliminary efficacy of psilocybin mushrooms to treat adults with PTSD. Up to 24 participants will take part in this study. Each participant will ingest psilocybin from dried mushrooms in a chocolate formulation.

Conditions Studied

PTSD

Interventions

  • DRUG Psychedelic

Study Locations (1)

Arizona

  • Scottsdale Research Institute - Scottsdale

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2026-02-09
Est. Completion 2026-03
Phase Phase 1

Sponsor

Suzanne "Sue" Sisley MD

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07275970

The ClinicalTrials.gov registry entry for NCT07275970 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (92% lower). The listed sponsor is Suzanne "Sue" Sisley MD, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with PTSD appearing as the primary indexed condition, and to 1 intervention - of which Psychedelic is the first listed.

NCT07275970 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT07275970 about?

NCT07275970 is a clinical study titled "Safety and Preliminary Efficacy of Organic Whole Psilocybin-Containing Mushrooms to Treat Patients Suffering From PTSD". This study will examine the safety and preliminary efficacy of psilocybin mushrooms to treat adults with PTSD. Up to 24 participants will take part in this study. Each participant will ingest psilocybin from dried mushrooms in a chocolate formulation.

What is the current status of trial NCT07275970?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2026-02-09. Estimated completion is 2026-03.

What conditions does trial NCT07275970 study?

This clinical trial studies the following conditions: PTSD.

What interventions are being tested in trial NCT07275970?

The interventions under investigation include: Psychedelic (DRUG).

Who is sponsoring clinical trial NCT07275970?

This trial is sponsored by Suzanne "Sue" Sisley MD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07275970 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for PTSD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

PTSD

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.